Th1 polarization in Familial Mediterranean fever

Journal of Rheumatology

Volumn 30, Issue 9, 2003, Pages 2011-2013

  Aypar, Ebru ^b   Ozen, Seza ^a   Okur, Homza ^b   Kutluk, Tezer ^b   Besbas, Nesrin ^b   Bakkaloglu, Aysin ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE

Author keywords

Familial mediterranean fever; Interferon ; Th cells; Th1; Th2

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; MONOCLONAL ANTIBODY;

AMYLOIDOSIS; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL MEDITERRANEAN FEVER; FEVER; FLUORESCENCE ACTIVATED CELL SORTING; GENE MUTATION; HUMAN; INFLAMMATION; MONONUCLEAR CELL; POLARIZATION; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; TURKEY (REPUBLIC);

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; MALE; PROBABILITY; REFERENCE VALUES; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TH1 CELLS;

EID: 0042694645     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997;90:797-807.
2. Ozen S. Vasculopathy, Behcet's disease and familial Mediterranean fever. Curr Opin Rheumatol 1999;11:393-8.
3. Centola M, Wood G, Frucht DM, et al. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 2000;95:3223-31.
4. Kastner DL. FMF: The genetics of inflammation. Hosp Prac 1998;33:131-46.
5. Romagnani S. Human TH1 and TH2 subsets: doubt no more. Immunol Today 1991;12:256-7.
6. Rostaing L, Tkaczuck J, Durand M, et al. Kinetics of intracytoplasmic Th1, and Th2 cytokine production assessed by flow cytometry following in vitro activation of peripheral blood mononuclear cells. Cytometry 1999;35:318-28.
7. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40:1879-85.
8. Tunca M, Kirkal G, Soyturk M, et al. Acute phase response and evolution of familial Mediterranean fever [letter]. Lancet 1999;353:1415.
9. Aksentijevich I, Torosyan Y, Samuels J, et al. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet 1999;64:949-62.
10. Yjlmaz E, Ozen S, Balci B, et al. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 2001;8:553-5.
11. Ozen S, Balci B, Ozkara S, et al. Was there a heterozygote advantage for FMF carriers against tuberculosis infections?: Speculations remain. Clin Exp Rheumatol 2002;20 Suppl 26:S57-58.
12. Bar-Eli M, Gallily R, Levy M, Eliakim M. Monocyte function in familial Mediterranean fever. Am J Med Sci 1977;274:265-70.
13. Ozyilkan E, Simsek H, Telatar H. Absence of asthma in patients with familial Mediterranean fever. Isr J Med Sci 1994;30:237-8.